AzurRx BioPharma Announces Completion of Enrollment in First Cohort of Phase 2b OPTION 2 Extension Study of MS1819

    NEXT STORY
    Medivolve Announces Investment Into Marvel Diagnostics and Its Non-Invasive Exhaled Breath Diagnostic Technology
    PREV STORY
    Sharps Compliance Reports Fiscal 2021 Second Quarter Results
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Reminder: Welcome to Elekta’s Capital Markets Presentation at ASTRO

    STOCKHOLM, September 13 – Elekta (EKTA-B.ST) welcomes you to its Capital Markets Presentation on ...

    author_avatar
    NASDAQ Market News

    South Korea IVD Market Report 2018

    Dublin, Jan. 02, 2019 (GLOBE NEWSWIRE) -- The "The IVD Market in South Korea" ...

    author_avatar
    NASDAQ Market News

    BeiGene to Hold Conference Call and Webcast on September 8, 2019 at 7:00 p.m. ET to Provide Corporate Update

    author_avatar
    NASDAQ Market News